Why are omnibus claims rejected in patent applications?
Omnibus claims are typically rejected in patent applications because they are considered indefinite. The MPEP 2173.05(r) states: “This claim should be rejected under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph, because it is indefinite in that it fails to point out what is included or excluded by the claim language.” In other…
Read MoreWho can file an affidavit or declaration under 37 CFR 1.130?
According to MPEP 2155.05, “the applicant or patent owner may submit an affidavit or declaration” under 37 CFR 1.130. This means that the person or entity who filed the patent application or owns the patent has the authority to file such documents. However, there’s an important distinction when the applicant is not the inventor: “When…
Read MoreWho can be named as an inventor on a patent application?
According to the Manual of Patent Examining Procedure (MPEP), an inventor must be a natural person. The MPEP states: “35 U.S.C. 100(f) defines the term ‘inventor’ as the individual or, if a joint invention, the individuals collectively who invented or discovered the subject matter of the invention.” This means that only individuals, not companies or…
Read MoreHow are “wherein” and “whereby” clauses interpreted in patent claims?
The interpretation of “wherein” and “whereby” clauses in patent claims depends on their specific context and effect on the claim. According to MPEP 2111.04: “The determination of whether each of these clauses is a limitation in a claim depends on the specific facts of the case.” For “wherein” clauses, they can be limiting if they…
Read MoreWhen can a patent examiner use the streamlined eligibility analysis?
When can a patent examiner use the streamlined eligibility analysis? A patent examiner can use the streamlined eligibility analysis when a claim, viewed as a whole, clearly does not attempt to tie up a judicial exception. The MPEP 2106.06 states: “This analysis can be used for claims that may or may not recite a judicial…
Read MoreWhen can an affidavit or declaration under 37 CFR 1.130(a) be used?
An affidavit or declaration under 37 CFR 1.130(a), also known as an affidavit or declaration of attribution, can be used in two specific situations: To establish that a disclosure was made by the inventor or joint inventor. To establish that the subject matter disclosed was obtained directly or indirectly from the inventor or joint inventor.…
Read MoreWhen should the markedly different characteristics analysis be performed?
The markedly different characteristics analysis should be performed when evaluating nature-based product limitations in a claim. However, it’s important to note that not all claims containing nature-based products require this analysis. According to the MPEP, “Examiners should keep in mind that if the nature-based product limitation is naturally occurring, there is no need to perform…
Read MoreWhen should an examiner search for foreign patents under pre-AIA 35 U.S.C. 102(d)?
An examiner should conduct a search for foreign patents under pre-AIA 35 U.S.C. 102(d) only under specific circumstances. The MPEP provides guidance on this: “The examiner should undertake a search for an issued foreign patent for use as pre-AIA 35 U.S.C. 102(d) prior art only if there is a reasonable possibility that a foreign patent…
Read MoreWhen does experimental use end in patent law?
Experimental use ends when the invention is actually reduced to practice. The MPEP states: “Experimental use ‘means perfecting or completing an invention to the point of determining that it will work for its intended purpose.’ Therefore, experimental use ‘ends with an actual reduction to practice.’” (MPEP 2133.03(e)(3)) Once the inventor is satisfied that the invention…
Read MoreWhen does experimental use of an invention end?
Experimental use of an invention ends when the invention is actually reduced to practice. According to the MPEP, Experimental use “means perfecting or completing an invention to the point of determining that it will work for its intended purpose.” Therefore, experimental use “ends with an actual reduction to practice.” (MPEP 2133.03(e)(3)) This means that once…
Read More